Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
Thonhofer
R
R
Gaugg
M
M
Kriessmayr
M
M
Neumann
H J
HJ
Erlacher
L
L
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D016393:Lymphoma, B-Cell / Q000139:chemically induced* / Q000276:immunology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009365:Neoplasm Regression, Spontaneous; D010255:Paranasal Sinus Neoplasms / Q000139:chemically induced* / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate